Composition
- Active ingredients
- CEFAZOLIN SODIUM EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFAZOLIN SODIUM EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050461-005 · Discontinued
- CEFAZOLIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050461-003 · Discontinued
- CEFAZOLIN SODIUM EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050461-001 · Discontinued
- CEFAZOLIN SODIUM EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- CEFAZOLIN SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050461-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050461.
At a glance
- Brand name
- Ancef
- Active substance
- cefazolin sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 4 Oct 1973
- Application
- NDA050461-004